Addex Therapeutics Ltd. (ADXN)
7.99
-0.01
(-0.12%)
USD |
NASDAQ |
Jan 23, 11:18
Addex Therapeutics Cash from Investing (Quarterly): 0.0379M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BeOne Medicines Ltd. | -49.28M |
| AC Immune SA | 26.82M |
| CRISPR Therapeutics AG | -119.23M |
| NewCelX Ltd. | -- |
| Molecular Partners AG | 14.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.6874M |
| Cash from Financing (Quarterly) | 0.4683M |
| Free Cash Flow | -1.995M |
| Free Cash Flow Per Share (Quarterly) | -0.7321 |
| Free Cash Flow to Equity (Quarterly) | -0.6851M |
| Free Cash Flow to Firm (Quarterly) | -0.6868M |
| Free Cash Flow Yield | -29.24% |